Development of quality indicators for an ethanol infusion in a glucose solution as an antidote for surrogate alcohol poisonings


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Intoxication with alcohol and its surrogates are continuously recorded in many countries of the world, being one of the leading causes of hospitalizations and death in patients with acute chemical poisonings. However, the Register of Medicines of the Russian Federation has not currently registered an antidote used to treat surrogate alcohol poisonings. Objective: to develop technology and parameters for standardization of ethanol infusions. Material and methods. Glucose (dextrose) and ethanol that met the requirements of Pharmaceutical Article (PA) 2.1.0036.15 of the 14th edition of the RF SP were utilized; the reverse osmosis system of the research and production association «Filterra» was used to prepare water. The quality indicators of the solution were determined using a «Svetlyachok» (Firefly) visual control device; a Mettler Toledo Five Easy 20 pH meter with a universal integrated LE438 IP67 electrode with temperature sensor, an IRF-454B2M laboratory refractometer and a Crystallux 4000M gas chromatograph with a flame ionization detector, and a sterilizer. The stability of the solution was determined in the IB-15G thermostat (JeioTech, Korea). Outbred albino male rats weighing 195-314 g were used to determine the efficacy of the obtained solution for acute methanol and ethylene glycol poisonings. Results. Procedures were developed for the qualitative and quantitative determination of ethanol and glucose in a 5% infusion of ethanol in a 5% glucose solution, by adding a Weibel stabilizer. The stability of the agent was evaluated under conditions of accelerated aging. The infusion solution of the proposed composition was found to be stable throughout the duration of the experiment, which corresponds to 3 years of room-temperature storage. The primary evaluation of the efficiency of using the ethanol infusion of the proposed composition was made according to the survival rate after experimental acute surrogate alcohol poisonings in laboratory animal experiments. Conclusion. A technology was developed to produce a 5% solution of ethanol in a 5% glucose solution. The parameters of standardization of this dosage form were proposed. The estimated expiration date was determined. The developed methods were validated.

Full Text

Restricted Access

About the authors

Maria Andreevna Grigoryeva

Saint Petersburg State Chemical Pharmaceutical University

Email: marija.grigoreva@pharminnotech.com
Student of the Pharmaceutical faculty

Olesya Nikolaevna Abrosimova

Saint Petersburg State Chemical Pharmaceutical University

Email: olesya.abrosimova@pharminnotech.com
Associate Professor of the Department of Department of Industrial Technology of Medicines

Olga Yuryevna Strelova

Saint Petersburg State Chemical Pharmaceutical University

Email: olga.strelova@pharminnotech.com
Head of the Department of Pharmaceutical Chemistry

Tatyana Yuryevna Ilyina

Saint Petersburg State Chemical Pharmaceutical University

Email: tatiana.ilyina@pharminnotech.com
Associate Professor of the Department of Pharmaceutical Chemistry

Alexander Nikolaevich Grebenyuk

Saint Petersburg State Chemical Pharmaceutical University

Email: grebenyuk_an@mail.ru
Professor of the Department of Pharmaceutical Chemistry SPbSCPhU, Doctor of Medical Sciences, Professor

References

  1. Гасанов И.И., Хабибулина Ж.Ю., Булычева О.С. Анализ роли суррогатных алкогольных напитков в формировании феномена высокой алкогольной смертности в мире. Успехи современного естествознания. 2013; 9: 92-3.
  2. Центр разработки национальной алкогольной политики. Доступно на http://www.alcomarket.info/CRNAP/. [Дата обращения -17.02.2019].
  3. Федеральные клинические рекомендации «Токсическое действие алкоголя». [Электронное издание]. Режим доступа: http://oms.karelia.ru/docs/federal_zakon/files/
  4. Гребенюк А.Н., Аксенова Н.В., Антушевич А.Е. и др. Токсикология и медицинская защита. СПб: Фолиант, 2016; 672.
  5. Бенеманский В.В., Юшков Г.Г., Бун М.М., Машанов А.В. Морфологические изменения печени при остром отравлении этиловым и пропиловым спиртами, этиленгликолем и их смесью. Бюллетень ВСНЦ СО РАМН. 2008; 4: 68-72.
  6. Москвичев В.Г., Верткин А.Л. Лечение неотложных состояний, связанных с употреблением алкоголя, в клинике внутренних болезней. Врач скорой помощи. 2007; 5: 58-69.
  7. Государственный Реестр лекарственных средств. [Электронное издание]. Режим доступа: https://grls.rosmin-zdrav.ru/grls.aspx (дата обращения: 05.10.2018).
  8. Государственная фармакопея РФ XIV изд. [Электронное издание]. Режим доступа: http://femb.ru/feml
  9. Об утверждении СП 2.2.1.3218-14 «Санитарноэпидемиологические требования к устройству, оборудованию и содержанию экспериментальнобиологических клиник (вивариев)». Постановление главного государственного санитарного врача РФ от 29.08.2014 № 51. Российская газета (специальный выпуск). 2015; 6 февраля: 24.
  10. Раскоша О.В., Кичигин А.И. Основные принципы надлежащей лабораторной практики (НЛП, GLP) при обустройстве вивария и организации научных исследований. Вестник института биологии Коми НЦ УрО РАН. 2016; 3 (197): 19-25.
  11. Guide for the care and use of laboratory animals. Vlll-th edition. Washington, D.C: The National Academies press. 2010; 218.
  12. Чуешов В.И., Гладух Е.В., Ляпунова О.А. и др. Промышленная технология лекарств. Харьков: Национальный фармацевтический университет. 2010; 769.
  13. Руководство по проведению доклинических исследований лекарственных средств. Часть 1. (под ред. А.Н. Миронова). М.: Гриф и К, 2013; 944.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies